Everence Capital Management Inc Abbott Laboratories Transaction History

Everence Capital Management Inc

$1.59 Billion
Q3 2024

A detailed history of Everence Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Everence Capital Management Inc holds 30,640 shares of ABT stock, worth $3.52 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

30,640

Previous 42,910 28.59%

Holding current value

$3.52 Million

Previous $4.55 Million 23.18%

% of portfolio

0.22%

Previous 0.32%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $1.23 Million - $1.45 Million	-12,270 Reduced 28.59%	30,640 $3.49 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $400,984 - $490,838	-4,446 Reduced 9.39%	42,910 $4.72 Million
Q3 2023 Oct 16, 2023	BUY	$95.53 - $114.62 $335,310 - $402,316	3,510 Added 8.01%	47,356 $4.59 Million
Q1 2023 Apr 04, 2023	BUY	$96.86 - $114.01 $392,283 - $461,740	4,050 Added 10.18%	43,846 $4.44 Million
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $1.03 Million - $1.21 Million	-10,830 Reduced 21.39%	39,796 $4.37 Million
Q2 2022 Jul 26, 2022	SELL	$102.07 - $123.37 $885,967 - $1.07 Million	-8,680 Reduced 14.64%	50,626 $5.5 Million
Q1 2022 Apr 11, 2022	BUY	$114.02 - $139.04 $1.02 Million - $1.24 Million	8,910 Added 17.68%	59,306 $7.02 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $1.07 Million - $1.31 Million	-9,240 Reduced 15.49%	50,396 $7.09 Million
Q2 2021 Jul 12, 2021	BUY	$105.79 - $124.53 $1.58 Million - $1.86 Million	14,920 Added 33.37%	59,636 $6.91 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $174,300 - $189,937	-1,660 Reduced 3.58%	44,716 $4.9 Million
Q3 2020 Feb 01, 2021	SELL	$91.64 - $111.29 $373,891 - $454,063	-4,080 Reduced 8.09%	46,376 $5.05 Million
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $43,494 - $48,419	554 Added 1.11%	50,456 $4.38 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $78,205 - $94,550	1,181 Added 2.42%	49,902 $3.99 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $135,810 - $145,399	-2,530 Reduced 4.94%	48,721 $2.78 Million
Q3 2017 Oct 31, 2017	BUY	$48.06 - $53.64 $2.46 Million - $2.75 Million	51,251	51,251 $2.74 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Abbott Laboratories Transaction History